documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

6 rows where docket_id = "FDA-2006-P-0006" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-P-0006-0006 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Citizen Petition from AAC Consulting Group Other Citizen Petition 2008-08-12T04:00:00Z 2008 8 2008-08-12T04:00:00Z   2024-11-14T14:48:47Z   1 0 090000648044143d
FDA-2006-P-0006-0005 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Letter from FDA CDER to AAC Consulting Group/Kendle Other Letter(s) 2007-11-30T05:00:00Z 2007 11     2024-11-14T14:39:25Z   0 0 0900006480441445
FDA-2006-P-0006-0004 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100 Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice N-Notice 2007-11-27T05:00:00Z 2007 11 2007-11-23T05:00:00Z   2024-11-14T14:37:17Z   0 0 0900006480441444
FDA-2006-P-0006-0003 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Letter from FDA CDER to AAC Consulting Group Other Letter(s) 2007-01-23T05:00:00Z 2007 1     2024-11-14T14:36:39Z   0 0 0900006480441443
FDA-2006-P-0006-0002 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Acknowledgment Letter from FDA DMB to AAC Consulting Group Other Acknowledgement Letter/Receipt 2006-07-25T04:00:00Z 2006 7     2024-11-14T14:31:40Z   0 0 090000648044143f
FDA-2006-P-0006-0001 FDA To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 Acknowledgment Letter from FDA DMB to AAC Consulting Group Other Acknowledgement Letter/Receipt 2006-07-25T04:00:00Z 2006 7     2024-11-14T14:22:37Z   0 0 090000648044143a

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);